Terms: = Liver cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Diagnosis
44 results:
1. Investigating the molecular mechanism of Qizhu anticancer prescription in inhibiting hepatocellular carcinoma based on high-resolution mass spectrometry and network pharmacology.
Sun J; Ma M; Zhong X; Li J; Yi J; Zhang R; Liu X; Peng L; Sun X; Feng W; Hu R; Huang Q; Lv M; Fan K; Zhou X
J Ethnopharmacol; 2024 Jun; 328():117985. PubMed ID: 38417600
[TBL] [Abstract] [Full Text] [Related]
2. Circ_MAPK9 promotes stat3 and LDHA expression by silencing miR-642b-3p and affects the progression of hepatocellular carcinoma.
Wang K; Lu Q; Luo Y; Yu G; Wang Z; Lin J; Tan Z; Lao Y; Liu S; Yang H
Biol Direct; 2024 Jan; 19(1):4. PubMed ID: 38163874
[TBL] [Abstract] [Full Text] [Related]
3. UBE2S promotes malignant properties via VHL/HIF-1α and VHL/JAK2/stat3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma.
Wu J; Xu X; Wu S; Shi W; Zhang G; Cao Y; Wang Z; Wu J; Jiang C
Cancer Med; 2023 Sep; 12(17):18078-18097. PubMed ID: 37563971
[TBL] [Abstract] [Full Text] [Related]
4. SSNA1 Promotes Hepatocellular Carcinoma Metastasis
Wu LW; Hu X
Anticancer Res; 2023 Aug; 43(8):3479-3486. PubMed ID: 37500134
[TBL] [Abstract] [Full Text] [Related]
5. Vasorin promotes proliferation and migration via stat3 signaling and acts as a promising therapeutic target of hepatocellular carcinoma.
Wan F; Li H; Huang S; Sun J; Li J; Li Y; Yang L; He M
Cell Signal; 2023 Oct; 110():110809. PubMed ID: 37454705
[TBL] [Abstract] [Full Text] [Related]
6. Construction of Two Independent RAB Family-Based Scoring Systems Based on Machine Learning Algorithms and Definition of RAB13 as a Novel Therapeutic Target for Hepatocellular Carcinoma.
Jiang C; Liu Z; Yuan J; Wu Z; Kong L; Yang J; Lv T
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901767
[TBL] [Abstract] [Full Text] [Related]
7. High Expression of POGK Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma.
Xu W; Huang Y; Mei Y; Zhang Y; Luo Q; Zhu S; Peng L; Gao Z; Liu Y; Li J
Curr Oncol; 2022 Nov; 29(11):8650-8667. PubMed ID: 36421335
[TBL] [Abstract] [Full Text] [Related]
8. Ethanolic extract of Coleus aromaticus leaves impedes the proliferation and instigates apoptotic cell death in liver cancer HepG2 cells through repressing JAK/STAT cascade.
Shekh R; Tiwari RK; Ahmad A; Ahmad I; Alabdallah NM; Saeed M; Ansari IA; Mishra A; Ashfaque M; Bajpai P
J Food Biochem; 2022 Oct; 46(10):e14368. PubMed ID: 35945689
[TBL] [Abstract] [Full Text] [Related]
9. HNRNPC downregulation inhibits IL-6/stat3-mediated HCC metastasis by decreasing HIF1A expression.
Liu D; Luo X; Xie M; Zhang T; Chen X; Zhang B; Sun M; Wang Y; Feng Y; Ji X; Li Y; Liu B; Huang W; Xia L
Cancer Sci; 2022 Oct; 113(10):3347-3361. PubMed ID: 35848884
[TBL] [Abstract] [Full Text] [Related]
10. The role of Tripartite motif containing 59 (TRIM59) in the proliferation and prognosis of intrahepatic cholangiocarcinoma.
Zhang JN; Ding DY; Yang SY; Tao QF; Yang Y; Zhou WP
Pathol Res Pract; 2022 Aug; 236():153989. PubMed ID: 35753134
[TBL] [Abstract] [Full Text] [Related]
11. Hepcidin in hepatocellular carcinoma.
Joachim JH; Mehta KJ
Br J Cancer; 2022 Jul; 127(2):185-192. PubMed ID: 35264787
[TBL] [Abstract] [Full Text] [Related]
12. The E3 ubiquitin ligase SOCS-7 reverses immunosuppression via Shc1 signaling in hepatocellular carcinoma.
Huang P; Zhao Z; Chen Y; Yang B; Xia J
Lab Invest; 2022 Jun; 102(6):613-620. PubMed ID: 35042950
[TBL] [Abstract] [Full Text] [Related]
13. Immune implication of an autophagy-related prognostic signature in uveal melanoma.
Chuah S; Chew V
Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34374416
[TBL] [Abstract] [Full Text] [Related]
14. PIWI‑interacting RNA in cancer: Molecular mechanisms and possible clinical implications (Review).
Yuan C; Qin H; Ponnusamy M; Chen Y; Lin Z
Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34328192
[TBL] [Abstract] [Full Text] [Related]
15. The Role of Fibroblast Growth Factor 19 in Hepatocellular Carcinoma.
Chen Z; Jiang L; Liang L; Koral K; Zhang Q; Zhao L; Lu S; Tao J
Am J Pathol; 2021 Jul; 191(7):1180-1192. PubMed ID: 34000282
[TBL] [Abstract] [Full Text] [Related]
16. CD63 negatively regulates hepatocellular carcinoma development through suppression of inflammatory cytokine-induced stat3 activation.
Yu S; Chen J; Quan M; Li L; Li Y; Gao Y
J Cell Mol Med; 2021 Jan; 25(2):1024-1034. PubMed ID: 33277798
[TBL] [Abstract] [Full Text] [Related]
17. Omics-Based Platforms: Current Status and Potential Use for Cholangiocarcinoma.
Chang YC; Chen MH; Yeh CN; Hsiao M
Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32998289
[TBL] [Abstract] [Full Text] [Related]
18. Nuclear ErbB2 expression in hepatocytes in liver disease.
Döring P; Calvisi DF; Dombrowski F
Virchows Arch; 2021 Feb; 478(2):309-318. PubMed ID: 32591879
[TBL] [Abstract] [Full Text] [Related]
19. Inhibiting effect of MicroRNA-3619-5p/PSMD10 axis on liver cancer cell growth in vivo and in vitro.
Hao P; Yue F; Xian X; Ren Q; Cui H; Wang Y
Life Sci; 2020 Aug; 254():117632. PubMed ID: 32437796
[TBL] [Abstract] [Full Text] [Related]
20. Modulation of stat3 Signaling, Cell Redox Defenses and Cell Cycle Checkpoints by β-Caryophyllene in Cholangiocarcinoma Cells: Possible Mechanisms Accounting for Doxorubicin Chemosensitization and Chemoprevention.
Di Sotto A; Di Giacomo S; Rubini E; Macone A; Gulli M; Mammola CL; Eufemi M; Mancinelli R; Mazzanti G
Cells; 2020 Apr; 9(4):. PubMed ID: 32252311
[TBL] [Abstract] [Full Text] [Related]
[Next]
